Liposomal NAD+ Contract Manufacturing for Nutraceutical Brands
KS Nutripharma delivers clinically oriented liposomal NAD+ formulation systems designed for brands targeting the high-growth longevity, cellular energy, and metabolic health markets.
Liposomal encapsulation is applied to stabilize NAD+ precursors and improve systemic delivery efficiency, addressing one of the core limitations in conventional NAD+ oral supplements: low bioavailability and rapid degradation in the gastrointestinal environment.
KS Nutripharma® operates as an OEM/ODM contract manufacturer, specializing in liposomal delivery system development and private-label production. It is built around turnkey formulation services that support global brands from product concept and formulation design to scalable manufacturing and compliant packaging for commercial supplement launches.
| 19+ Years Nutraceutical Manufacturing | 81,000 m² GMP-Compliant Facility | 12 Production Lines |
| 500+ Brands Served Globally | 60+ Export Markets | 2 Dedicated R&D Centers |
| 5 M Capsules / Day | 2M Softgels / Day | 12M Tablets / Day |
| 2 M Gummies / Day | 7 International Certifications | 100% Batch Traceability |
Dedicated Liposome Production Infrastructure
- High-Pressure Homogenization Systems: Industrial-scale high-pressure homogenization systems optimized for liposome formation, particle size reduction, and batch-to-batch consistency.
- Liposomal Drying Technologies — Spray-dried and freeze-dried manufacturing options selected according to formulation characteristics, stability objectives, dosage form, and commercial positioning.
- Liposome Characterization — In-house characterization capabilities including particle size distribution, polydispersity index (PDI), encapsulation efficiency evaluation, and zeta potential analysis for formulation optimization and quality verification.
- Powder Redispersibility – Evaluation of powder redispersibility after reconstitution to support consistent product performance.
- Process Scale-Up Engineering – Process transfer from laboratory development to pilot production and full-scale commercial manufacturing while maintaining critical quality attributes.
- Dynamic Light Scattering (DLS)— In-house particle size analysis.
- HPLC Analytical Laboratory—Analytical laboratory supporting raw material identification, assay verification, encapsulation efficiency studies, stability evaluation, and finished product quality control.
- Phospholipid Carrier Development— Scientific selection and optimization of phospholipid carrier systems based on ingredient compatibility, phosphatidylcholine content, dosage form, and stability requirements.
- ICH-Compliant Stability Chambers— Stability studies designed according to ICH guidelines, including evaluation of particle size stability, encapsulation integrity, moisture control, and active ingredient retention throughout shelf life.
- Pilot Development & Process Validation— Pre-commercial validation batches (1–10 kg powder; 5,000–50,000 finished units), supports formulation optimization, engineering verification, process scale-up, and commercial readiness prior to full-scale manufacturing.
Market-Proven Liposomal NAD+ Formula
The following formulation architecture reflects the most widely commercialized NAD+ booster products across North America and Europe, combining cellular energy support with healthy aging positioning.
- NMN (Nicotinamide Mononucleotide)
- Nicotinamide Riboside (NR)
- NAD+ (optional premium positioning)
- Trans-Resveratrol
- TMG (Trimethylglycine)
- Quercetin
- Vitamin B12
- Riboflavin (Vitamin B2)
- Non-GMO Sunflower Phospholipids
- Phosphatidylcholine-Enriched Liposomes
- High-Pressure Homogenization Technology
- Cellular Energy
- Healthy Aging
- DNA Repair Support
- NAD+ Optimization
- Daily Longevity
High-Growth Formulation Trends (2026+)
Premium longevity brands are rapidly moving from single-ingredient NAD+ products toward multi-pathway cellular health systems.
- Spermidine
- Urolithin A
- Ca-AKG
- PQQ
- Coenzyme Q10
- Ergothioneine
- Fisetin
- Apigenin
- Astaxanthin
- Tocotrienols
- Alpha-Lipoic Acid
- Reduced Glutathione
- Citicoline (CDP-Choline)
- Phosphatidylserine
- Lion’s Mane Mushroom
- Bacopa Monnieri
- Rhodiola Rosea
- Ashwagandha
- L-Theanine
- Magnesium
- Liposomal Nicotinamide Riboside (NR)
- Nicotinamide Riboside (NR)
- Trigonelline
- TMG (Betaine)
- Resveratrol
- Pterostilbene
- Advanced Longevity
- Healthy Cellular Aging
- Mitochondrial Function
- Cellular Renewal
- Premium Biohacking
- Healthy Lifespan Support
Compatible Functional Ingredients
For OEM customization, liposomal NAD+ systems are compatible with the following ingredient categories:
Available Dosage Forms & Commercial Manufacturing Strategy
Liposomal NAD+ formulations require dosage forms that preserve ingredient stability while supporting premium positioning in the longevity market. The optimal format depends on formulation architecture, target consumer, and commercial strategy.
Designed for premium longevity formulations requiring maximum consumer perception.
Best suited for:
- Liposomal NAD+ liquid systems
- NAD+ + CoQ10
- NAD+ + PQQ
- NAD+ + Vitamin D3
Key commercial characteristics:
- Premium appearance and higher perceived value
- Excellent protection against oxidation
- Higher active payload capacity
- Ideal for premium retail positioning
Limitations:
- Higher manufacturing complexity
- Higher MOQ and production cost
Typical MOQ:
- ~8,500 finished units (60-count)
- ~500,000 bulk softgels
Strategic implication:
Softgels support premium pricing and are ideal for brands targeting the high-end longevity and biohacking markets.
The most widely adopted format for liposomal NAD+ supplements.
Best suited for:
- Liposomal NAD+
- NAD+ + NMN
- NAD+ + NR
- Longevity multi-ingredient complexes
Key commercial characteristics:
- Cost-effective and scalable manufacturing
- Excellent compatibility with dry liposomal powder technology
- Suitable for global retail and e-commerce channels
- Clean-label, vegan-friendly positioning
Limitations:
- Moderate payload compared with softgels
- Requires optimized moisture control during production
Typical MOQ:
- ~2,500 finished units (60-count)
- ~150,000 capsules bulk
Strategic implication:
The preferred entry format for most NAD+ supplement brands due to its balance of stability, scalability, and commercial flexibility.
A premium delivery format emphasizing rapid absorption and advanced technology.
Best suited for:
- Pure Liposomal NAD+
- NAD+ + NMN
- NAD+ + Resveratrol
- NAD+ longevity blends
Key commercial characteristics:
- Strong “advanced delivery” positioning
- Flexible daily dosing
- High perceived bioavailability
- Premium direct-to-consumer appeal
Limitations:
- More demanding flavor masking
- Higher logistics and packaging costs
- Shelf life management after opening
Typical MOQ:
- ~5,000 units
- ~100 gallons bulk
Strategic implication:
Liquid liposomal systems are premium products suited for brands focused on innovation and consumer experience.
Convenient, travel-friendly delivery designed for premium wellness consumers.
Best suited for:
- Liposomal NAD+ daily wellness programs
- NAD+ + Collagen
- NAD+ + Beauty-from-within formulas
Key commercial characteristics:
- Precise single-dose convenience
- Excellent portability
- Premium consumer perception
- Popular for subscription and DTC brands
Limitations:
- Higher packaging costs
- Greater manufacturing complexity
Typical MOQ:
- ~1,500 finished units
- ~1,000 kg bulk
Strategic implication:
Single-serve sachets provide strong product differentiation and support premium pricing.
An increasingly popular format combining manufacturing flexibility with formulation stability.
Best suited for:
- Dry liposomal NAD+
- NAD+ + NMN complexes
- Multi-ingredient longevity formulas
Key commercial characteristics:
- Improved stability during transportation
- Flexible dosage customization
- Suitable for capsules and stick packs
- Lower logistics costs than liquid systems
Limitations:
- Requires specialized dry liposomal technology
- Flavor optimization needed for beverage applications
Typical MOQ:
- ~1,500 finished units
- ~1,000 kg bulk
Strategic implication:
Powder systems offer an efficient solution for scalable global OEM production.
Designed for modern wellness routines and active consumers.
Best suited for:
- NAD+ + Electrolytes
- NAD+ + Vitamin C
- NAD+ + Energy support blends
Key commercial characteristics:
- Convenient on-the-go consumption
- High compliance
- Strong lifestyle positioning
- Flexible serving sizes
Limitations:
- Flavor masking challenges
- Moisture-sensitive packaging requirements
Typical MOQ:
- ~2,500 finished units
Strategic implication:
Stick packs are increasingly adopted by premium lifestyle and sports nutrition brands.
An accessible dosage form targeting broader wellness consumers.
Best suited for:
- Entry-level NAD+ support
- Beauty and healthy aging formulas
Key commercial characteristics:
- Excellent consumer acceptance
- Attractive for younger demographics
- Strong retail visibility
Limitations:
- Limited active ingredient loading
- Heat and moisture sensitivity
- Less suitable for high-dose NAD+ formulations
Typical MOQ:
- ~2,500 finished units (60-count)
Strategic implication:
Gummies serve as complementary products for portfolio expansion rather than flagship longevity SKUs.
Core Engineering Parameters for Liposomal Delivery Systems
Liposomal performance is determined not only by ingredient selection, but by precise control of structural and physicochemical properties at the nanoscale level. These parameters directly influence formulation stability, manufacturing reproducibility, and commercial product consistency.
For OEM brand owners, these quality attributes define the difference between a basic liposomal product and a high-performance delivery system suitable for premium global markets.
Particle size is a critical determinant of liposomal system behavior in both formulation stability and oral delivery performance.
Optimized nanoscale particle size supports:
- Stable dispersion in liquid or dry systems
- Consistent formulation appearance across production batches
- Controlled delivery performance in finished supplements
Uniform particle size distribution is essential for maintaining product quality during manufacturing, storage, and distribution.
Encapsulation efficiency reflects how effectively active ingredients are incorporated into the phospholipid vesicle structure.
High EE% contributes to:
- Improved protection of sensitive active compounds
- More efficient utilization of raw materials
- Greater formulation consistency in commercial production
This parameter is a key indicator of liposomal system engineering quality and manufacturing precision.
PDI measures the uniformity of particle size distribution within the formulation.
A lower PDI indicates:
- More homogeneous liposomal structure
- Improved batch consistency
- Greater predictability in formulation behavior
PDI is widely used as a standard quality control metric in advanced liposomal systems.
Zeta potential represents the surface charge of liposomal particles and is a key indicator of colloidal stability.
Optimized zeta potential helps:
- Reduce particle aggregation
- Maintain dispersion stability during storage
- Support long-term physical integrity of the formulation
It is a critical parameter for ensuring stable commercial shelf performance.
Chemical stability evaluates the resistance of active ingredients and phospholipid structures to degradation under environmental stress.
This includes:
- Oxidative stress
- Hydrolytic degradation
- Temperature and humidity exposure
Strong chemical stability helps preserve formulation integrity throughout manufacturing, storage, and distribution cycles.
The quality and composition of phospholipids directly influence liposomal structure formation and functional performance.
High-quality phospholipid systems:
- Enhance membrane integrity
- Support consistent vesicle formation
- Improve reproducibility in large-scale manufacturing
Phospholipid selection is a foundational factor in liposomal delivery system design.
Consistency across production batches is essential for commercial supplement brands operating in regulated global markets.
Controlled manufacturing systems ensure:
- Stable particle characteristics across batches
- Reliable formulation performance
- Predictable product quality for retail distribution
Batch consistency is a key requirement for scalable OEM/ODM partnerships.
Shelf stability testing evaluates product performance under real-time and accelerated storage conditions.
This ensures:
- Structural integrity of liposomal systems over time
- Preservation of active ingredient functionality
- Compliance with international distribution requirements
Shelf stability is critical for retail, export, and long-term brand reputation.
Conventional oral NAD+ supplementation presents formulation challenges related to molecular stability and bioavailability. Liposomal delivery technology is designed to improve ingredient protection and optimize delivery efficiency, providing a differentiated solution for premium longevity supplements.
Market Challenges
As consumer awareness of cellular health and healthy aging continues to grow, expectations have shifted beyond ingredient dosage alone. Buyers increasingly seek delivery technologies that enhance formulation quality, product differentiation, and overall consumer confidence.
Conventional NAD+ supplements often compete primarily on dosage and price, making it difficult for brands to establish meaningful differentiation in an increasingly competitive longevity category.
Core Formulation Challenges
Limited Oral Stability
NAD+ is sensitive to gastrointestinal conditions, where degradation may reduce the amount of active ingredient available for absorption.
Delivery Efficiency
The hydrophilic nature and molecular characteristics of NAD+ present formulation challenges for efficient oral delivery.
Premium Product Differentiation
As the longevity category matures, ingredient-only positioning is becoming less effective for brands seeking premium market placement.
Liposomal Engineering Solutions
Our phospholipid-based liposomal delivery platform is developed to address these formulation challenges through advanced encapsulation technology.
Enhanced Ingredient Protection
A phospholipid bilayer helps protect active ingredients during gastrointestinal transit, improving formulation stability before absorption.
Optimized Delivery System
Liposomes are structurally similar to biological cell membranes, enabling efficient interaction with lipid-based absorption pathways and supporting improved bioavailability.
Improved Formulation Stability
Liposomal encapsulation helps reduce oxidation and moisture exposure, contributing to greater product stability throughout manufacturing and shelf life.
Technology-Driven Product Differentiation
Liposomal delivery provides a clear technological advantage that supports premium positioning beyond ingredient dosage alone.
Commercial Benefits for Brand Owners
Premium Market Positioning
Liposomal NAD+ supports premium branding in the rapidly expanding longevity, healthy aging, and cellular wellness categories.
Higher Product Differentiation
Delivery technology creates stronger competitive advantages than ingredient-only formulations, helping brands avoid price-based competition.
Flexible Formula Expansion
The liposomal platform is compatible with numerous longevity ingredients, allowing rapid development of complete product portfolios, including:
- NMN
- Nicotinamide Riboside (NR)
- Coenzyme Q10
- PQQ
- Urolithin A
- Spermidine
- Fisetin
- Apigenin
- Reduced Glutathione
- Resveratrol
Stronger Consumer Value Perception
Consumers increasingly associate advanced delivery technologies with higher-quality formulations, supporting premium pricing strategies and stronger brand credibility.
Why Liposomal Delivery Matters
Rather than relying solely on higher ingredient dosages, liposomal technology focuses on improving formulation efficiency through advanced phospholipid encapsulation.
This approach addresses several important formulation objectives:
- Protect sensitive active ingredients
- Improve formulation stability
- Optimize oral delivery efficiency
- Support premium product positioning
- Create meaningful technical differentiation
Ideal Applications
Liposomal NAD+ formulations are well suited for brands developing products for:
- Healthy Aging
- Cellular Energy
- Longevity
- Mitochondrial Health
- Cognitive Wellness
- Active Lifestyle
- Premium Biohacking
- Daily Wellness
Yes. Besides liposomal NAD+ supplements, we also provide OEM and private label manufacturing for liposomal nicotinamide riboside supplements. Formulation options include standalone NR, NR with TMG, resveratrol, pterostilbene, CoQ10, and other longevity-focused ingredients.
The primary difference lies in the active ingredient and how it supports cellular NAD+ levels.
A liposomal NAD supplement delivers nicotinamide adenine dinucleotide (NAD+) directly within a liposomal delivery system. It is designed for brands targeting cellular energy, mitochondrial function, and healthy aging through direct NAD+ supplementation.
A liposomal NR supplement contains nicotinamide riboside (NR), a naturally occurring form of vitamin B3 and a well-studied NAD+ precursor. After absorption, NR is converted by the body’s metabolic pathways into NAD+, helping support intracellular NAD+ production.
From a commercial perspective, both ingredients are positioned in the longevity and healthy aging category but appeal to different market segments:
| Liposomal NAD Supplement | Liposomal NR Supplement |
|---|---|
| Contains NAD+ as the active ingredient | Contains nicotinamide riboside (NR), an NAD+ precursor |
| Focuses on direct NAD+ supplementation | Supports the body’s natural NAD+ biosynthesis |
| Often positioned for premium longevity and biohacking products | Widely recognized through scientific research on NAD+ metabolism and healthy aging |
| Frequently combined with CoQ10, PQQ, or resveratrol | Commonly formulated with TMG, pterostilbene, CoQ10, or ergothioneine |
As an OEM/ODM manufacturer, we support the development of both liposomal NAD supplements and liposomal nicotinamide riboside (NR) supplements, with customized formulations, dosage forms, flavor systems, and private label solutions tailored to different market positioning and regulatory requirements.
| Stage | Timeline | Key Deliverables |
| 1. Inquiry | 1–3 days | Requirements document; initial feasibility assessment |
| 2. Formula & Quotation | 3–7 days | Custom formula proposal; pricing; regulatory pathway review |
| 3. Sample | 1–2 weeks | Physical sample with COA; organoleptic evaluation |
| 4. Pilot Batch | 2–3 weeks | 1–10 kg powder or 5,000–50,000 units; stability samples retained |
| 5. Scale-Up | 3–4 weeks | Process parameter lock; equivalence data; batch record validation |
| 6. Commercial Production | Per schedule | Full-scale manufacturing; in-process controls; finished product testing |
| 7. QC Release & Delivery | 1–2 weeks | Final COA; regulatory documentation; export logistics |
Commercial Production Overview
Formula Design → Pilot Batch → Scale-Up Validation → Commercial Production → QC Testing → Global Delivery
| Packaging Format | Barrier Properties | Best For | Shelf Life Support |
| Aluminum Laminate Pouches | Excellent moisture, oxygen, and light barrier | Stick packs; bulk powder; export shipments | 24–36 months |
| HDPE Bottles + Induction Seal | Good moisture barrier; moderate oxygen barrier | Standard retail; North American market | 18–24 months (with desiccant) |
| Blister Packs (Alu-Alu) | Excellent individual dose protection; zero moisture transmission | Pharmacy channel; clinical trials; premium positioning | 24–36 months |
| Amber Glass Bottles | Excellent light protection; good oxygen barrier (with proper seal) | Liquid formulations; premium positioning | 12–18 months (liquid) |
| Nitrogen-Flushed Containers | Displaced oxygen reduces oxidation risk | High-value formulations; extended shelf life targets | +6–12 months extension |
Packaging Components
- Desiccants:Silica gel canisters (1–3 g per bottle, depending on headspace volume) for powder products
- Oxygen Absorbers:Iron-based scavengers for oxygen-sensitive formulations
- Nitrogen Flushing:Applied during filling to reduce headspace oxygen to <3%
- Secondary Packaging:Cartons with UV varnish for light protection; tamper-evident seals
Storage Recommendations
| Product Form | Recommended Storage | Acceptable Range | Critical Warnings |
| Powder (spray-dried) | 15–25°C; <60% RH | 5–30°C; <75% RH | Protect from moisture and direct sunlight |
| Powder (freeze-dried) | 2–8°C preferred; 15–25°C acceptable | 2–30°C; <60% RH | Refrigeration extends shelf life; protect from moisture |
| Liquid suspension | 2–8°C | 2–25°C (short-term) | Shake well before use; do not freeze |
| Capsule / Softgel | 15–25°C; <60% RH | 5–30°C; <75% RH | Protect from heat and humidity |
Standard Batch Documentation
- Certificate of Analysis (COA)— Batch-specific test results for all specification parameters
- Product Specification— Complete quality specification with test methods and acceptance criteria
- Technical Data Sheet (TDS)— Product description, composition, physicochemical properties, handling guidelines
- Material Safety Data Sheet (MSDS)— Safety information, hazard classification, handling precautions, first aid
- Residual Solvent Report— GC-MS analysis confirming compliance with ICH Q3C limits
- Heavy Metal Report— ICP-MS data for Pb, Cd, As, Hg
- Microbiology Report— TAMC, TYMC, specified organism testing per USP <61>, <62>
- Stability Summary— Available stability data with storage conditions and retest period
Regulatory & Compliance Statements
- Allergen Statement— Free from major allergens; customizable per market requirements
- Non-GMO Statement— Available for non-GMO formulations
- BSE/TSE Statement— Free from bovine spongiform encephalopathy / transmissible spongiform encephalopathy risk materials
- Halal Certificate— Available upon request
- Kosher Certificate— Available upon request
- ISO 22000— Certified
- FSSC 22000— Certified
- cGMP Compliance— Per 21 CFR Part 111 (US) and applicable EU regulations
Ready to Develop Your Liposomal NAD+ Product with KS Nutripharma?
Whether you are launching a new premium liposomal supplement or expanding your existing product portfolio, our formulation scientists and manufacturing team are ready to support every stage of development—from concept and pilot production to full-scale commercial manufacturing.
Let’s Build Your Next Liposomal Supplement Together
✔ Custom Formula Development
✔ OEM & Private Label Manufacturing
✔ Pilot Batch Production
✔ Regulatory Documentation
✔ Global Export Support
Request a Formula Consultation | Request Samples | Get an OEM Quotation
